Form 4 for MRK Merck & Co.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-04 · accession 0001127602-24-014269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-04 | MRK | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $127.51 | +27.1K | 163.7K | +20% | +$3.46M |
| D | 2024-05-06 | 2024-05-04 | MRK | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | F - Tax | $127.51 | -13.4K | 150.4K | -8% | -$1.70M |
| D | 2024-05-06 | 2024-05-04 | MRK | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $0.00 | -27.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-04 | M | A | 27,126 | $127.51 | 163,719.56 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-04 | F | D | 13,360 | $127.51 | 150,359.56 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Derivative | Restricted Stock Unit | 2024-05-04 | M | D | 27,126 | $0.00 | 0 | D | — · 2024-05-04 to 2024-05-04 | 27,126 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F4) These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024. |